<DOC>
	<DOCNO>NCT01870050</DOCNO>
	<brief_summary>Principal aim study ass whether combination topical dapsone clobetasol topical steroid superior clobetasol alone treatment prurigo nodularis lichen simplex chronicus side side comparison . The study primarily exploratory essentially meant inform sponsor whether development combination treatment formulation warrant</brief_summary>
	<brief_title>Dapsone Prurigo Study</brief_title>
	<detailed_description />
	<mesh_term>Prurigo</mesh_term>
	<mesh_term>Neurodermatitis</mesh_term>
	<mesh_term>Dapsone</mesh_term>
	<criteria>• Active prurigo nodularis lichen simplex chronicus diagnose clinical exam For lichen simplex chronicus patient : Severity maximum pruritus last 24 hrs least 5 10 visual analogue scale . For prurigo nodularis patient : Excoriations sign scratch relate activity presentation demonstrate active disease Symmetrical disease/excoriations allow sidebyside comparison ( eg , bilateral lichen simplex chronicus bilateral prurigo nodularis ) genitals , face , axillae neck use sidetoside comparison Willing refrain use topical medication treatment area . Able willing provide write informed consent Willing able understand comply requirement study , apply treatment combination instructs , attend require study visit , comply study prohibition able complete study . Male nonpreganant , nonlactating female 18 75 year age , inclusive For female childbearing potential , willing use adequate birth control study conduct • History noncompliance follow visit Should exclude failure certain treatment exclusion criterion ? Patients fail oral dapsone exclude Presence skin condition treatment area would interfere diagnosis assessment active lichen simplex chronicus and/or prurigo nodularis ( eg , rosacea , dermatitis , psoriasis , squamous cell carcinoma , eczema , acneform eruption cause medication , steroid acne , steroid folliculitis bacterial folliculitis ) Excessive hair treatment area would interfere diagnosis assessment lichen simplex chronicus and/or prurigo nodularis History hypersensitivity allergy topical steroid , dapsone , treatment product component Use tan booth , sunbathe excessive exposure sun study Consumes excessive amount alcohol , abuse drug , condition would compromise compliance protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>lichen simplex chronicus</keyword>
	<keyword>prurigo</keyword>
</DOC>